Published on:

Drug Law Round-up

  • SCOTUS says that drug-labeling laws that require generic drugs to use the same labels as their name-brand equivalents mean patients taking the generic version of Reglan can’t sue over failure to warn.
  • Abnormal Use writes about the possible preemption fallout from the FDA’s Avastin decision.
  • Vitamins recalled for failure to meet standards for child-resistant caps.
  • How dangerous is Chantix to the heart?
  • This is not exactly a drug, but the FTC has now made sure Nivea can no longer imply in advertisements that one of its skin lotion products will make you skinnier. (HT:Legal Blog Watch.)